Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

Active Rheumatoid Arthritis Clinical Trial

Official title:
Long-term Treatment Study of CDP870 Self-injection. A Multicenter, Open-label, Long-term Safety Study to Evaluate the Safety and Efficacy of CDP870 Self-injection Administered at a Dose of 200 mg Biweekly for 24 Weeks or Longer in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 Administered Concomitantly With or Without Methotrexate (MTX)

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the safety and efficacy of CDP870 self-injection administered for 24 weeks or longer in subjects who are participating in the long-term treatment study (Study 275-08-002 or Study 275-08-004) of CDP870 administered concomitantly with or without Methotrexate.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02586246
Study type	Interventional
Source	Astellas Pharma Inc
Contact
Status	Completed
Phase	Phase 3
Start date	January 2011
Completion date	May 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04472481` - Vitamin D Effect in Rheumatoid Arthritis.	Phase 4
Completed	`NCT00959036` - Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis	Phase 1/Phase 2
Completed	`NCT00913458` - Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis	Phase 4
Completed	`NCT01961505` - Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis	N/A
Completed	`NCT00393471` - Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.	Phase 3
Not yet recruiting	`NCT03346590` - Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects	N/A
Terminated	`NCT02534896` - To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis	Phase 3
Completed	`NCT03172325` - Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA	Phase 3
Completed	`NCT00420199` - A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate	Phase 3
Completed	`NCT00882024` - Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)	Phase 2
Completed	`NCT03599986` - Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
Completed	`NCT01008852` - Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis	Phase 2